DZ Bank Reaffirms “Buy” Rating for Lanxess (LXS)
Lanxess (ETR:LXS)‘s stock had its “buy” rating reiterated by stock analysts at DZ Bank in a research note issued to investors on Wednesday.
A number of other research analysts also recently weighed in on the stock. Deutsche Bank set a €69.00 ($82.14) target price on shares of Lanxess and gave the company a “neutral” rating in a research report on Wednesday. UBS set a €75.00 ($89.29) price objective on shares of Lanxess and gave the stock a “buy” rating in a report on Wednesday. Kepler Capital Markets set a €83.00 ($98.81) price objective on shares of Lanxess and gave the stock a “buy” rating in a report on Tuesday, November 28th. Jefferies Group set a €69.00 ($82.14) price objective on shares of Lanxess and gave the stock a “neutral” rating in a report on Tuesday, November 28th. Finally, Macquarie set a €75.00 ($89.29) price objective on shares of Lanxess and gave the stock a “buy” rating in a report on Thursday, October 26th. Twelve research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Lanxess has a consensus rating of “Hold” and an average price target of €70.95 ($84.46).
Lanxess (LXS) traded down €0.17 ($0.20) during trading on Wednesday, hitting €64.85 ($77.20). 211,764 shares of the stock were exchanged, compared to its average volume of 382,271. Lanxess has a 1 year low of €59.89 ($71.30) and a 1 year high of €70.67 ($84.13).
Lanxess Company Profile
LANXESS Aktiengesellschaft develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in four segments: Advanced Intermediates, Performance Chemicals, High Performance Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemicals and coatings industries; fine chemicals as precursors and intermediates for pharmaceuticals, agrochemicals, and specialty chemicals industries; customer-specific specialties; and tire chemicals.
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.